Aging Research and Drug Discovery Meeting in Copenhagen

We’re excited to share that Michael Schaeffler, our experienced project lead in the pharmaceutical sector, will be attending the Aging Research and Drug Discovery Meeting at the University of Copenhagen from August 25-29.

Michael is an expert in the field of Rapamycin and its potential in longevity research. If you’re working on age-related therapies or exploring innovative approaches to healthy aging, he’s the right person to talk to.

Whether you’re looking to exchange ideas, discuss research challenges, or explore collaboration opportunities: Michael will be happy to connect.

Let us know if you’ll be there too!